HomeInsightsPE

Sun Pharmaceuticals Industries Ltd PE Ratio

Sun Pharmaceuticals Industries Ltd PE Ratio

stocks purchased

₹ 2.4 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

13.3 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PE

38.6

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd is 38.6 as of 12 Dec 9.00 AM .
  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd changed from 43.1 on March 2019 to 40.6 on March 2024 . This represents a CAGR of -0.99% over 6 years.
  • The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1804 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

No data available

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

Share Price

₹ 1804.45

-10.25 (-0.56%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20241804.45
11 Dec 20241814.7
10 Dec 20241809.45
09 Dec 20241806.2
06 Dec 20241804.8
05 Dec 20241809.65
04 Dec 20241800.05
03 Dec 20241798.6
02 Dec 20241808.2
29 Nov 20241781.65

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Sun Pharmaceuticals Industries Ltd384,32,948
Divis Laboratories Ltd861,57,873
Cipla Ltd251,16,809
Torrent Pharmaceuticals Ltd641,12,638
Mankind Pharma Ltd501,06,198
Dr Reddys Laboratories Ltd191,03,963

Key Valuation Metric of Sun Pharmaceuticals Industries Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in %

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is...

Read more

2024-08-20 00:00:00

News

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US...

Read more

2024-08-14 00:00:00

News

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on Yo...

Read more

2024-08-01 00:00:00

News

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarte...

Read more

2024-08-01 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sun Pharmaceuticals Industries Ltd

What is the current PE Ratio of Sun Pharmaceuticals Industries Ltd?

The Current PE Ratio of Sun Pharmaceuticals Industries Ltd is 38.62 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Sun Pharmaceuticals Industries Ltd last year?

The PE Ratio of Sun Pharmaceuticals Industries Ltd was 27.83 last year, now the PE ratio is 38.62, showing a year-on-year growth of 38.8%.

What does the PE Ratio of Sun Pharmaceuticals Industries Ltd indicate about its stock?

The PE Ratio of Sun Pharmaceuticals Industries Ltd is 38.62. This ratio indicates that investors are willing to pay 38.62 times the earnings per share for each share of Sun Pharmaceuticals Industries Ltd.

What is the PE Ratio Growth of Sun Pharmaceuticals Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharmaceuticals Industries Ltd grew by 38.8% whereas, the EPS ratio grew by 7.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions